198 related articles for article (PubMed ID: 26076810)
1. DNA methylation as a promising landscape: A simple blood test for breast cancer prediction.
Khakpour G; Pooladi A; Izadi P; Noruzinia M; Tavakkoly Bazzaz J
Tumour Biol; 2015 Jul; 36(7):4905-12. PubMed ID: 26076810
[TBL] [Abstract][Full Text] [Related]
2. Methylomics of breast cancer: Seeking epimarkers in peripheral blood of young subjects.
Khakpour G; Noruzinia M; Izadi P; Karami F; Ahmadvand M; Heshmat R; Amoli MM; Tavakkoly-Bazzaz J
Tumour Biol; 2017 Mar; 39(3):1010428317695040. PubMed ID: 28349825
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation and breast cancer: A way forward (Review).
Vietri MT; D'Elia G; Benincasa G; Ferraro G; Caliendo G; Nicoletti GF; Napoli C
Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34726251
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly methylated DNA as a biomarker in breast cancer.
Kristiansen S; Jørgensen LM; Guldberg P; Sölétormos G
Int J Biol Markers; 2013; 28(2):141-50. PubMed ID: 23564623
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation-based biomarkers in serum of patients with breast cancer.
Van De Voorde L; Speeckaert R; Van Gestel D; Bracke M; De Neve W; Delanghe J; Speeckaert M
Mutat Res; 2012; 751(2):304-325. PubMed ID: 22698615
[TBL] [Abstract][Full Text] [Related]
7. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
[TBL] [Abstract][Full Text] [Related]
8. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M
Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119
[TBL] [Abstract][Full Text] [Related]
9. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].
Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E
Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modifications in breast cancer and their role in personalized medicine.
Stefansson OA; Esteller M
Am J Pathol; 2013 Oct; 183(4):1052-1063. PubMed ID: 23899662
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
[TBL] [Abstract][Full Text] [Related]
13. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
[TBL] [Abstract][Full Text] [Related]
14. Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients.
Li Z; Guo X; Wu Y; Li S; Yan J; Peng L; Xiao Z; Wang S; Deng Z; Dai L; Yi W; Xia K; Tang L; Wang J
Breast Cancer Res Treat; 2015 Feb; 149(3):767-79. PubMed ID: 25636590
[TBL] [Abstract][Full Text] [Related]
15. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
[TBL] [Abstract][Full Text] [Related]
16. Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
Győrffy B; Bottai G; Fleischer T; Munkácsy G; Budczies J; Paladini L; Børresen-Dale AL; Kristensen VN; Santarpia L
Int J Cancer; 2016 Jan; 138(1):87-97. PubMed ID: 26174627
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation age is elevated in breast tissue of healthy women.
Sehl ME; Henry JE; Storniolo AM; Ganz PA; Horvath S
Breast Cancer Res Treat; 2017 Jul; 164(1):209-219. PubMed ID: 28364215
[TBL] [Abstract][Full Text] [Related]
18. The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer.
Chaligné R; Popova T; Mendoza-Parra MA; Saleem MA; Gentien D; Ban K; Piolot T; Leroy O; Mariani O; Gronemeyer H; Vincent-Salomon A; Stern MH; Heard E
Genome Res; 2015 Apr; 25(4):488-503. PubMed ID: 25653311
[TBL] [Abstract][Full Text] [Related]
19. The relative contribution of DNA methylation and genetic variants on protein biomarkers for human diseases.
Ahsan M; Ek WE; Rask-Andersen M; Karlsson T; Lind-Thomsen A; Enroth S; Gyllensten U; Johansson Å
PLoS Genet; 2017 Sep; 13(9):e1007005. PubMed ID: 28915241
[TBL] [Abstract][Full Text] [Related]
20. Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers.
Jones A; Lechner M; Fourkala EO; Kristeleit R; Widschwendter M
Epigenomics; 2010 Feb; 2(1):9-38. PubMed ID: 22122746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
